Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Condition: Advanced Solid Tumour
NCT07111546
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.